Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 7 Breast Neoplasms 3 Zollinger-Ellison Syndrome 1 Triple Negative Breast Neoplasms 1 Stomach Ulcer 1 Solid Tumours 1 Solid Tumor 1 Prostate Cancer Patients 1 Pharmacokinetics of MDV3100 1 Ovarian Neoplasms 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell, Marginal Zone 1 Hodgkin Disease 1 Healthy Adult Participants 1 Esophagitis, Peptic 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Medullary 1 Breast Neoplasms, Male 1 Advanced Solid Tumours 1 Advanced Solid Tumors 1 Advanced Solid Tumor 1 Adult Solid Neoplasm 1

Interventions

Cyclophosphamide 24 fludarabine phosphate 22 Filgrastim 15 Gemcitabine 14 fludarabine 13 Rituximab 13 Brentuximab Vedotin 13 Peripheral Blood Stem Cell Transplantation 12 Whole-Body Irradiation 11 Vorinostat 11 Tacrolimus 11 Bortezomib 10 Mycophenolic Acid 9 Melphalan 9 Etoposide 9 Busulfan 9 Sirolimus 8 Lenalidomide 8 Azacitidine 8 Nivolumab 7 Dexamethasone 7 pembrolizumab 6 Radiotherapy 6 Cytarabine 6 Antilymphocyte Serum 6 romidepsin 5 aldesleukin 5 Panobinostat 5 Leucovorin 5 Doxorubicin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Hodgkin Disease × Omeprazole × Clear all

NCT06383338 2025-09-08

PEGASUS

Murdoch Childrens Research Institute

Phase 1 Recruiting

Hodgkin Disease, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡